Latest Updates on Chinese Business Legal Affairs, 29th Series: Current Risks of Non-Compliance in China and Penalties Therefor - GSK China's Commercial Bribery Case where a 53 Billion Yen Fine was Imposed
Authors：
Fumi Takatsuki
Magazine/Book：JCA JOURNAL
Date of publication：
November, 2014
Other publications by Fumi Takatsuki
- 2023.02.27
- China’s Life Science and Healthcare-No.3 Amendment of the Regulations on Cosmetics in China
- 2022.03.14
- A Legal Review of China’s Life Sciences and 2 Healthcare- No.1 －General Introduction and MAH System
- 2017.12.27
- 100 Selected Cases in China, Series 250
